Biofrontera
Stock Forecast, Prediction & Price Target
Biofrontera Financial Estimates
Biofrontera Revenue Estimates
Biofrontera EBITDA Estimates
Biofrontera Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $24.1M N/A | $28.67M 18.97% | $34.07M 18.82% | Avg: $49.71M Low: $48.20M High: $51.22M avg. 45.91% | Avg: $68.14M Low: $66.06M High: $70.21M avg. 37.06% | Avg: $86.11M Low: $83.49M High: $88.73M avg. 26.37% | Avg: $110.61M Low: $107.25M High: $113.98M avg. 28.45% |
Net Income
% change YoY
| $-37.71M N/A | $-640K 98.30% | $-20.13M -3045.46% | Avg: $-3.87M Low: $-417.5K High: $-355.64K avg. 80.77% | Avg: $6.15M Low: $608.91K High: $659.07K avg. 258.95% | Avg: $1.19M Low: $1.14M High: $1.23M avg. -80.64% | Avg: $2.35M Low: $2.25M High: $2.44M avg. 97.40% |
EBITDA
% change YoY
| $-25.16M N/A | $-21.17M 15.84% | $-18.45M 12.85% | Avg: $-29.95M Low: $-30.86M High: $-29.04M avg. -62.33% | Avg: $-41.05M Low: $-42.30M High: $-39.80M avg. -37.06% | Avg: $-51.88M Low: $-53.46M High: $-50.30M avg. -26.37% | Avg: $-66.64M Low: $-68.67M High: $-64.62M avg. -28.45% |
EPS
% change YoY
| -$44.1 N/A | -$0.61 98.61% | -$13.02 -2034.42% | Avg: -$0.25 Low: -$0.27 High: -$0.23 avg. 98.07% | Avg: $0.41 Low: $0.39 High: $0.43 avg. 263.99% | Avg: $0.77 Low: $0.74 High: $0.8 avg. 87.80% | Avg: $1.52 Low: $1.46 High: $1.58 avg. 97.40% |
Operating Expenses
% change YoY
| $37.20M N/A | $35.87M -3.59% | $39.30M 9.57% | Avg: $58.99M Low: $57.20M High: $60.79M avg. 50.09% | Avg: $80.86M Low: $78.40M High: $83.32M avg. 37.06% | Avg: $102.18M Low: $99.07M High: $105.29M avg. 26.37% | Avg: $131.26M Low: $127.27M High: $135.25M avg. 28.45% |
FAQ
What is Biofrontera stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 89.11% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -417.5K, average is -3.87M and high is -355.64K.
What is Biofrontera stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 34.45% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $48.20M, average is $49.71M and high is $51.22M.
What is Biofrontera stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 136.82% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.27, average is -$0.25 and high is $-0.23.